Fasting blood glucose level and prognosis in non-small cell lung cancer (NSCLC) patients

Lung Cancer

Volumn 76, Issue 2, 2012, Pages 242-247

  Luo, Juhua ^a,b   Chen, Yea Jyh ^c   Chang, Li Jung ^d  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

^c WEST VIRGINIA UNIVERSITY SCHOOL OF NURSING   (United States)

^d TZU CHI COLLEGE OF TECHNOLOGY   (Taiwan)

Author keywords

Diabetes; Fasting blood glucose; Non small cell lung carcinoma; Prognostic factors

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CENTER; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER PROGNOSIS; CANCER STAGING; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HAZARD RATIO; HUMAN; HYPERGLYCEMIA; KAPLAN MEIER METHOD; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OVERALL SURVIVAL; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SMOKING; TEACHING HOSPITAL;

AGED; BLOOD GLUCOSE; CARCINOMA, NON-SMALL-CELL LUNG; DIABETES MELLITUS; FASTING; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERGLYCEMIA; LUNG NEOPLASMS; MALE; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SMOKING;

EID: 84859432857     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2011.10.019     Document Type: Article

References (25)

1. Giovannucci E., Harlan D.M., Archer M.C., Bergenstal R.M., Gapstur S.M., Habel L.A., et al. Diabetes and cancer: a consensus report. Diabetes Care 2011, 33:1674-1685.
2. Friberg E., Orsini N., Mantzoros C.S., Wolk A. Diabetes mellitus and risk of endometrial cancer: a meta-analysis. Diabetologia 2007, 50:1365-1374.
3. Larsson S.C., Mantzoros C.S., Wolk A. Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer 2007, 121:856-862.
4. Barone B.B., Yeh H.C., Snyder C.F., Peairs K.S., Stein K.B., Derr R.L., et al. Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA 2008, 300:2754-2764.
5. LeRoith D., Novosyadlyy R., Gallagher E.J., Lann D., Vijayakumar A., Yakar S. Obesity and type 2 diabetes are associated with an increased risk of developing cancer and a worse prognosis; epidemiological and mechanistic evidence. Exp Clin Endocrinol Diabetes 2008, 116(Suppl. 1):S4-S6.
6. Nerlich A.G., Hagedorn H.G., Boheim M., Schleicher E.D. Patients with diabetes-induced microangiopathy show a reduced frequency of carcinomas. In Vivo 1998, 12:667-670.
7. Peairs K.S., Barone B.B., Snyder C.F., Yeh H.C., Stein K.B., Derr R.L., et al. Diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis. J Clin Oncol 2011, 29:40-46.
8. Stein K.B., Snyder C.F., Barone B.B., Yeh H.C., Peairs K.S., Derr R.L., et al. Colorectal cancer outcomes, recurrence, and complications in persons with and without diabetes mellitus: a systematic review and meta-analysis. Dig Dis Sci 2011, 55:1839-1851.
9. De Giorgio R., Barbara G., Cecconi A., Corinaldesi R., Mancini A.M. Diabetes is associated with longer survival rates in patients with malignant tumors. Arch Intern Med 2000, 160. 2217-2217.
10. Satoh H., Ishikawa H., Kurishima K., Ohtsuka M., Sekizawa K. Diabetes is not associated with longer survival in patients with lung cancer. Arch Intern Med 2001, 161. 485-485.
11. Hanbali A., Al-Khasawneh K., Cole-Johnson C., Divine G., Ali H. Protective effect of diabetes against metastasis in patients with non-small cell lung cancer. Arch Intern Med 2007, 167. 513-513.
12. Park S.M., Lim M.K., Shin S.A., Yun Y.H. Impact of prediagnosis smoking, alcohol, obesity, and insulin resistance on survival in male cancer patients: National Health Insurance Corporation Study. J Clin Oncol 2006, 24:5017-5024.
13. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Thun M.J. Cancer statistics, 2009. CA Cancer J Clin 2009, 59:225-249.
14. Oken M.M., Creech R.H., Tormey D.C., Horton J., Davis T.E., McFadden E.T., et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982, 5:649-655.
15. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40:373-383.
16. Brundage M.D., Davies D., Mackillop W.J. Prognostic factors in non-small cell lung cancer - a decade of progress. Chest 2002, 122:1037-1057.
17. Cox D., Oakes D. Analysis of survival data 1984, Chapman & Hall, London, United Kindom.
18. Fujisawa T., Lizasa T., Saitoh Y., Sekine Y., Motohashi S., Yasukawa T., et al. Smoking before surgery predicts poor long-term survival in patients with stage I non-small-cell lung carcinomas. J Clin Oncol 1999, 17:2086-2091.
19. Kawai H., Tada A., Kawahara M., Nakai K., Maeda H., Saitou R., et al. Smoking history before surgery and prognosis in patients with stage IA non-small-cell lung cancer - a multicenter study. Lung Cancer 2005, 49:63-70.
20. Tammemagi C.M., Neslund-Dudas C., Simoff M., Kvale P. Impact of comorbidity on lung cancer survival. Int J Cancer 2003, 103:792-802.
21. van de Poll-Franse L.V., Houterman S., Janssen-Heijnen M.L.G., Dercksen M.W., Coebergh J.W.W., Haak H.R. Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis. Int J Cancer 2007, 120:1986-1992.
22. Varlotto J., Medford-Davis L.N., Recht A., Flickinger J., Schaefer E., Shelkey J., et al. Confirmation of the role of diabetes in the local recurrence of surgically resected non-small cell lung cancer. Lung Cancer 2011.
23. Richardson L.C., Pollack L.A. Therapy insight: influence of type 2 diabetes on the development, treatment and outcomes of cancer. Nat Clin Pract Oncol 2005, 2:48-53.
24. Yu H., Spitz M.R., Mistry J., Gu J., Hong W.K., Wu X. Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis. J Natl Cancer Inst 1999, 91:151-156.
25. O'Byrne K.J., Dalgleish A.G., Browning M.J., Steward W.P., Harris A.L. The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease. Eur J Cancer 2000, 36:151-169.